Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrIMO: Safety of PrEP During Pregnancy and Breastfeeding in Malawi
NCT06158126Phase 4Recruiting
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Apr 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cabotegravir in human immunodeficiency virus infection (HIV), sponsored by University of North Carolina at Chapel Hill. Started Apr 2024; status: recruiting.
02
Drugs
cabotegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT06158126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06158126.